Copper (serum)

Serum copper rises markedly in pregnancy due to estrogen-stimulated ceruloplasmin synthesis. Levels peak in mid-pregnancy and remain elevated until delivery.

Units Nonpregnant Adult 1st Trimester 2nd Trimester 3rd Trimester
µg/dL 70 – 140 112 – 199 165 – 221 130 – 240
µmol/L 11 – 22 18 – 31 26 – 35 21 – 38
Pregnancy physiology
  • Estrogen increases hepatic ceruloplasmin synthesis → higher serum copper.
  • Values rise 2–3× above baseline by mid-pregnancy.
  • Essential for fetal neurodevelopment, collagen formation, bone growth, and angiogenesis.
  • Ceruloplasmin-bound copper increases most; free copper remains low.
Causes of elevated copper
  • Normal pregnancy (physiologic)
  • Oral contraceptives / estrogen therapy
  • Inflammation (ceruloplasmin is an acute-phase reactant)
  • Cholestatic liver disease
  • High environmental or dietary copper exposure
  • Menkes carriers (mild increase)
  • Post–iron chelation therapy (ceruloplasmin rebound)

Marked copper elevation suggests inflammation, hepatobiliary disease, or excessive copper exposure rather than pregnancy alone.

Causes of decreased copper
  • Wilson disease (low ceruloplasmin + low copper)
  • Menkes disease (severe congenital deficiency)
  • Malnutrition or malabsorption (celiac disease, Crohn disease, bariatric surgery)
  • Nephrotic syndrome
  • Protein-losing enteropathy
  • Severe liver failure
  • Excess zinc intake (competitive inhibition)

True copper deficiency in pregnancy is uncommon and usually reflects malnutrition or impaired absorption.

References

  1. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–31.